Elad Walach is a co-founder and CEO of Aidoc, a healthcare AI startup focused on using deep learning to relieve the bottleneck in medical image diagnosis. He is an expert in AI with visionary business insights in the healthcare space. Since establishing Aidoc in early 2016, Elad has led the company through through 3 rounds of investment raising $60M, driven the commercial availability of 6 product lines: detecting brain hemorrhages, C-spine fractures, large vessel occlusions, free gas in the abdomen, pulmonary embolism and incidental pulmonary embolism, 5 of which are FDA cleared. Under Elad’s leadership, Aidoc has managed to grow it’s install base to 400 global hospitals while growing the company to over 120 employees.
Elad takes pride in remaining an on-the-ground leader for the company and looks for continuous improvement in himself and team. By looking to constantly challenge the status quo of the industry, Aidoc has been able to become a world leader in AI use in radiology.
Elad began his career in the elite Israeli Defense Force technology program “Talpiot”. He led AI research in the Israeli Air Force where he initiated and led several teams focused on machine learning and computer vision projects. Elad holds a B.Sc. in Mathematics and Physics from the Hebrew University of Jerusalem and published multiple academic papers on deep learning.
Elad is featured in numerous publications and was recently listed in Forbes 30 Under 30 Europe Science and Healthcare category. Read here for further information about the company and about this award.
Within the history of healthcare innovation lies the profound lessons surrounding the adoption of revolutionary technologies. Whether it be unleashing genomic sequencing to personalize oncologic
I was reading a Politico article the other day titled “Artificial intelligence was supposed to transform health care. It hasn’t.” The headline was certainly thought
AI is the new standard of care. There’s no turning back. Hospitals are growing much warmer to the idea of AI and its integration. But
Since medical imaging AI is often used as a diagnostic-aid tool, algorithms are evaluated on accuracy the same way as most other medical tests. From
On April 6th, Aidoc announced a partnership with Radiology Partners, the largest radiology practice in the United States, to offer enterprise AI capabilities to the
Aidoc recently launched the first AI-based automated activation solution that facilitates rapid risk assessment and care coordination for intermediate to high and high-risk pulmonary embolism
There are many reasons to found a startup. But one of the key ones for us was to bring together a group of people who
Elad Walach, CEO at Aidoc shares his predictions about the world of radiology artificial intelligence (AI) for 2021.
CMS have finally approved the first reimbursement opportunity for AI – specifically for computer-assisted triage and notification for patients with suspicion of stroke.
If I had told you four months ago that the growing trend of increased demand for medical imaging would plummet due to a global pandemic
This week, we received FDA clearance for the triage of Large-Vessel Occlusion (LVO) in head CTA scans, completing the commercial availability of our stroke package
The individual’s learning process is a core part of what contributes to the success of a startup. People often ask me what made me think I
For safety information on Aidoc products, please visit our safety and compliance page at https://www.aidoc.com/quality-compliance/
